FDA MAP
  • Home
  • Training
    • WORKSHOPS
    • WEBINARS
    • CUSTOM TRAINING
  • SERVICES
    • REGULATORY SERVICES
    • FDA AUDITING
    • QUALITY ASSURANCE
    • CLINICAL TRIAL SERVICES
  • News Releases
  • About Us
Webinars >>FDA Approval
How to Apply for Emergency Use Authorizations (EUA) for Various FDA Regulated Products

The Emergency Use Authorization (EUA) authority permits FDA to assist strengthen the nation’s public health protections against CBRN threats by facilitating the supply and use of MCMs required throughout public health emergencies.
The webinar will help in determining your eligibility while applying for the EUA and will cover the following topics:
​
  • The pre-EUA process
  • Diagnostics for a new disease
  • Drugs: new, repurposed and off-label use of approved drugs
  • Biologics: Vaccines, antibody and cellular therapies
  • Special release of products by FDA

​Who Should Attend:
​
  • Supervisors, Managers in Operational Management and Regulatory affairs
  • Project management personnel
  • Senior management executives (CEO, COO, CFO, etc)
  • Manufacturing managers, supervisors & personnel
  • Crisis managers, disaster management and business continuity management personnel
  • People investing in FDA-regulated product development projects
Date: December 23, 2020
​Duration: 60 Minutes
​
Time: 12 PM EST
Register Online

Speaker: Mukesh Kumar
​
PhD, RAC | Brij Strategic Consultations, 
 USA
​

Picture

    For more info, fill the box below. We will contact you within 24 hrs.

Submit
For additional information on the workshop agenda and logistics, please call 410-501-5777 or email: info@fdamap.com

Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions
  • Corporate Registration
  • Certification Program
  • Smart Recruitment
  • Corporate Registration - Online Workshop​

Company

  • About Us​
  • Testimonials
  • Free Resources
  • Newsletter
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2022 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.